Preparation, characterization, and stability of lipid nanoparticles including unsaturated lipids

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Among the SARS-CoV-2 vaccines developed to date, the mRNA vaccines developed by the Pfizer/BioNTech and Moderna companies have been formulated using saturated lipids, specifically 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), along with cholesterol. DSPC and cholesterol have the disadvantage of causing sclerosis. Therefore, in this study, lipid nanoparticles (LNPs) were prepared and characterized by replacing DSPC with 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and excluding cholesterol. The results showed that the DOPC-based LNPs had a smaller diameter (75.67nm) compared to the previous study and the polydispersity index (PI) indicated a good dispersion homogeneity, suggesting size uniformity. Additionally, the LNPs maintained their size between 57nm and 152nm and showed stable PI values (0.330-0.393) throughout the 25 days.

Original languageEnglish
Pages (from-to)594-598
Number of pages5
JournalTenside, Surfactants, Detergents
Volume60
Issue number6
DOIs
StatePublished - Nov 2023

Keywords

  • atherosclerosis
  • ethanol injection method
  • lipid nanoparticle
  • polydispersity index
  • unsaturated lipid

Fingerprint

Dive into the research topics of 'Preparation, characterization, and stability of lipid nanoparticles including unsaturated lipids'. Together they form a unique fingerprint.

Cite this